BioRestorative Therapies (BRTX) 10-K2016 FY Annual report

Filed: 22 Mar 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: agenda, aggrement, Analogue, announced, awaiting, biodistribution, bioengineered, biomaterial, built, clarify, cleanroom, Constance, contrast, DHI, earnable, East, effectivein, endpoint, father, FCA, headcount, height, histology, hyperlipidemia, immunomodulation, impracticable, literature, matrix, multiple, ODI, Orthobond, Oswestry, overt, paracrine, passage, Placebo, point, puncture, PuraCap, rabbit, radiographic, randomized, rebate, Relationship, Responder, SportsCare, Stanley, statistically, Statute, STC, Subscription, telemedicine, theStem, tight, toStem, toxicity, underlyingStem, underwent, Upper, VAS, vi, virtual

Removed: adulterated, alternatively, Amit, ANDA, ANDMANAGEMENT, Antonio, appointing, cancelled, Cardiothoracic, century, color, commencement, concentrating, conform, conformance, consecutive, consumer, earn, Ember, envision, escalating, executed, execution, fewer, floor, FPLA, half, hand, implicit, initiated, Joel, Jupiter, launched, leased, Maryland, misbranded, monograph, official, Patel, piggyback, protectant, punitive, redeem, reformulation, relabeling, resolution, restraining, San, separately, short, straight, substantiating, successive, sunscreen, supplier, surrender, TDA, truthful, unspecified, Vintage, widespread

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BRTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.68

December 14, 2016

John M. Desmarais

26 Deer Creek Lane

Mt. Kisco, New York 10549

Dear John:

Reference is made to the Promissory Note of even date from BioRestorative Therapies, Inc. (the “Company”) to you with respect to a loan made by you to the Company in the amount of $60,000.

In consideration of your loan, the Company agrees that the expiration dates of the Warrants, dated March 18, 2016, issued to you for the purchase of 444,444 and 400,000 shares of the Company’s Common Stock, respectively (the “Warrants”), are extended to December 31, 2018.

Except as modified herein, the Warrants shall continue in full force and effect in accordance with their terms.

	Very truly yours,

	BioRestorative Therapies, Inc.

	By:
		Mark Weinreb, Chief Executive Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.